COMPARATIVE IMMUNOHISTOCHEMICAL ESTROGEN-RECEPTOR ANALYSIS IN PRIMARYAND METASTATIC UVEAL MELANOMA

Citation
T. Makitie et al., COMPARATIVE IMMUNOHISTOCHEMICAL ESTROGEN-RECEPTOR ANALYSIS IN PRIMARYAND METASTATIC UVEAL MELANOMA, Graefe's archive for clinical and experimental ophthalmology, 236(6), 1998, pp. 415-419
Citations number
35
Categorie Soggetti
Ophthalmology
ISSN journal
0721832X
Volume
236
Issue
6
Year of publication
1998
Pages
415 - 419
Database
ISI
SICI code
0721-832X(1998)236:6<415:CIEAIP>2.0.ZU;2-K
Abstract
Background: The investigation reported here was carried out to determi ne the oestrogen receptor status of metastatic and primary uveal melan omas. Methods: A series of 23 primary and 24 metastatic formalin-fixed , paraffin-embedded choroidal melanomas were analysed immunohistochemi cally with the monoclonal antibody (MAb) 1D5 using the avidin-biotinyl ated peroxidase method and antigen retrieval with microwaves. Melanoph ages were identified with MAb PC-Mi to macrophages. Results: None of t he primary or metastatic melanomas contained tumour cells that would h ave shown a nuclear immunoreaction for oestrogen receptors with MAb 1D 5. However, in 20 of the 23 primary tumours and in 14 of the 24 metast ases a variable number of infiltrating cells showed a strong positive cytoplasmic immunoreaction with MAb 1D5. The cells contained pigmented cytoplasmic granules that resisted bleaching of melanin and their cyt oplasm was strongly labelled with MAb PC-Mi, identifying them as cross -reacting macrophages. Conclusion: Oestrogen receptors can not be used as a prognostic indicator if anti-oestrogen therapy is considered for treatment of metastatic uveal melanoma. However, because anti-oestrog ens also act by other mechanisms on both tumour and host tissues, the lack of oestrogen receptors does not automatically negate their therap eutic effect in disseminated melanoma.